Pfizer Inc. to cancel listing in the United Kingdom
22 February 2017
Pfizer Inc. (NYSE:PFE) (the "Company") today announced that it has applied to the United Kingdom Listing Authority ("UKLA") to cancel the standard listing of the Company's common stock ("Common Stock") from the Official List of the UKLA and the cancellation of trading in the Company's Common Stock on the Main Market of the London Stock Exchange (together, the "Cancellation"), following a determination by the Company that there is limited trading or liquidity of its Common Stock on the Main Market of the London Stock Exchange. The Company also announced today that it will be cancelling the listing of its Common Stock from the SIX Swiss Exchange for the same reasons.
The effective date of the Cancellation is intended to be 23 March 2017. Following the de-listing, the Company will continue to list its Common Stock on the New York Stock Exchange under the symbol "PFE".
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...